Otros idiomas Krebs Biochemicals & Industries Limited NSE India S.E.

Acciones

KREBSBIO

INE268B01013

Diferido NSE India S.E. Otros sitios de cotización 05:48:43 02/07/2024			Varia. Cinco días.	Varia. 1 de enero.
74,96 ^INR	+2,06 %		+6,04 %	-4,33 %

21/05	Krebs Biochemicals & Industries Limited nombra a Rakesh Kalbate Secretario de la Compañía/Oficial de Cumplimiento	CI
21/05	Krebs Biochemicals & Industries Limited informa de los resultados del cuarto trimestre y del año completo finalizado el 31 de marzo de 2024	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Krebs Biochemicals & Industries Limited Appoints Rakesh Kalbate as Company Secretary/Compliance Officer	21/05
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	21/05
Krebs Biochemicals & Industries Limited Announces Resignation of Keyur Doshi as Company Secretary, Compliance Officer	15/04
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	12/02
Krebs Biochemicals & Industries Limited Appoints Keyur Doshi as Company Secretary, Compliance Officer	17/01
Andhra Pradesh Pollution Control Board Orders Production Halt at Krebs Biochemicals Plant	18/12
Krebs Biochemicals & Industries Limited Announces Resignation of Rohit Taparia as Company Secretary and Compliance Officer	20/10/23
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	09/08/23
Krebs Biochemicals & Industries Limited Approves Resignation of Mr. Pabitrakumar Kalipada Bhattacharya as Managing Director	09/08/23
Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023	09/08/23
Krebs Biochemicals Trims Net Loss in Fiscal Q4	24/05/23
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	24/05/23
Krebs Biochemicals Names New CFO	03/02/23
Krebs Biochemicals & Industries Limited Approves Appointment of Rohit Taparia as Company Secretary and Compliance Officer	03/02/23
Krebs Biochemicals & Industries Limited Approves CFO Changes	03/02/23
Krebs Biochemicals & Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/11/22
Krebs Biochemicals & Industries Limited Auditor Raises 'Going Concern' Doubt	06/09/22
Krebs Biochemicals & Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	01/08/22
Taruni Banda Resigns as Company Secretary and Compliance Officer of Krebs Biochemicals & Industries Limited, Effective from August 6, 2022	01/08/22
Krebs Biochemicals & Industries : Financial Result Updates	23/05/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Krebs Biochemicals & Industries Limited NSE India S.E.

Acciones

KREBSBIO

INE268B01013

Otros idiomas

Filtros